National Pension Service Has $114.40 Million Stock Position in CVS Health Corp (NYSE:CVS)

National Pension Service grew its stake in shares of CVS Health Corp (NYSE:CVS) by 7.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,539,928 shares of the pharmacy operator’s stock after buying an additional 104,227 shares during the quarter. National Pension Service’s holdings in CVS Health were worth $114,401,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in CVS. Archer Investment Corp bought a new stake in shares of CVS Health during the fourth quarter worth about $2,657,000. Geode Capital Management LLC lifted its holdings in CVS Health by 1.8% during the 4th quarter. Geode Capital Management LLC now owns 18,668,143 shares of the pharmacy operator’s stock worth $1,384,017,000 after buying an additional 337,843 shares in the last quarter. Muhlenkamp & Co. Inc. lifted its holdings in CVS Health by 52.1% during the 4th quarter. Muhlenkamp & Co. Inc. now owns 106,514 shares of the pharmacy operator’s stock worth $7,913,000 after buying an additional 36,479 shares in the last quarter. Integrated Wealth Concepts LLC lifted its holdings in CVS Health by 14.7% during the 4th quarter. Integrated Wealth Concepts LLC now owns 6,283 shares of the pharmacy operator’s stock worth $467,000 after buying an additional 807 shares in the last quarter. Finally, Transcend Wealth Collective LLC acquired a new position in CVS Health during the 4th quarter worth $317,000. Hedge funds and other institutional investors own 77.52% of the company’s stock.

In related news, COO Jonathan C. Roberts sold 57,563 shares of CVS Health stock in a transaction dated Wednesday, January 8th. The shares were sold at an average price of $72.63, for a total transaction of $4,180,800.69. Following the completion of the transaction, the chief operating officer now directly owns 102,608 shares of the company’s stock, valued at approximately $7,452,419.04. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Larry J. Merlo sold 266,476 shares of CVS Health stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $74.79, for a total transaction of $19,929,740.04. Following the completion of the transaction, the chief executive officer now directly owns 703,497 shares of the company’s stock, valued at $52,614,540.63. The disclosure for this sale can be found here. Company insiders own 0.53% of the company’s stock.

A number of research analysts have recently weighed in on the company. Robert W. Baird cut their price target on CVS Health from $73.00 to $62.00 and set a “neutral” rating on the stock in a research note on Friday. Raymond James reiterated a “strong-buy” rating and issued a $90.00 price target (up from $80.00) on shares of CVS Health in a research report on Wednesday, December 4th. JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $88.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, December 19th. Credit Suisse Group reiterated a “hold” rating and issued a $75.00 price target on shares of CVS Health in a research report on Thursday, March 19th. Finally, Oppenheimer assumed coverage on shares of CVS Health in a research report on Wednesday, February 12th. They issued a “hold” rating for the company. One analyst has rated the stock with a sell rating, five have given a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $80.16.

Shares of NYSE:CVS traded up $0.29 on Friday, hitting $58.60. The company had a trading volume of 15,031,246 shares, compared to its average volume of 10,654,797. CVS Health Corp has a 1 year low of $51.72 and a 1 year high of $77.03. The firm has a market capitalization of $69.96 billion, a price-to-earnings ratio of 11.54, a P/E/G ratio of 1.16 and a beta of 0.97. The firm’s 50-day simple moving average is $64.03 and its two-hundred day simple moving average is $68.37. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 1.30.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.68 by $0.05. CVS Health had a net margin of 2.58% and a return on equity of 14.87%. The company had revenue of $66.89 billion during the quarter, compared to analysts’ expectations of $64.01 billion. During the same period last year, the company posted $2.14 EPS. CVS Health’s revenue was up 22.9% on a year-over-year basis. Equities research analysts anticipate that CVS Health Corp will post 7.13 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, May 4th. Investors of record on Thursday, April 23rd will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, April 22nd. This represents a $2.00 dividend on an annualized basis and a yield of 3.41%. CVS Health’s dividend payout ratio (DPR) is currently 28.25%.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Featured Article: Trading Options- What is a Strangle?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.